The in vitro Effect of Doxorubicine-G2-FA Treatment on Breast Cancer Copyright
(ندگان)پدیدآور
Mansoor Lakooraj, HamedKhaki, ZohrehGhorbani, MasoudShafiee Ardestani, MehdiDezfoulian, Omidنوع مدرک
TextClinical Pathology
زبان مدرک
Englishچکیده
BACKGROUND: To achieve delivery of a drug to tumors, folic acid (FA) was used as a targeting ligand to change nanocarriers. Since the folate receptor has more expression in several tumor types such as breast cancer. OBJECTIVES: The present study aimed to evaluate the effect of Doxorubicine-G2-FA (Dox- G2-FA) with in vitro assays. The abbreviation of G2 represents the second generation of dendrimer synthesis. METHODS: For this purpose, Dox-G2-FA was synthesized and mass spectroscopy was used to confirm the synthesized component. Also, MTT assay, flow cytometry, and gene expression assay by real-time PCR were used to evaluate cell viability, apoptosis, and necrosis. RESULTS: In this study, the effect of Dox and Dox-G2-FA on the expression of Bax, Bcl2 genes showed that there was a significant decrease in the expression of the Bcl2 gene in the Dox-G2-FA group compared to Dox and control groups(   P Dox-G2-FA was greater than in the Dox group (   P CONCLUSIONS: Therefore, it seems that the effect of Dox-G2-FA on apoptosis is better than the effect of Dox usage alone.
کلید واژگان
ApoptosisBax
Bcl2
Breast Cancer
Doxorubicine-G2-folate
شماره نشریه
2تاریخ نشر
2020-06-011399-03-12
ناشر
University of Tehranدانشگاه تهران
سازمان پدید آورنده
1Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, IranDepartment of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
Pasteur Institute of Iran, Research and Production Complex, Department of Research and Development
3Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad, Iran
شاپا
2251-88942252-0554




